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Screening medical patients for distress and
depression: does measurement in the clinic
prior to the consultation overestimate distress
measured at home?
C. H. Hansen1, J. Walker2, P. Thekkumpurath1, A. Kleiboer1, C. Beale1, A. Sawhney1, G. Murray3
and M. Sharpe2*
1 Psychological Medicine Research, School of Molecular and Clinical Medicine, University of Edinburgh, UK
2 Psychological Medicine Research, Department of Psychiatry, University of Oxford, UK
3 Centre for Population Health Sciences, University of Edinburgh, UK
Background. Medical patients are often screened for distress in the clinic using a questionnaire such as the Hospital
Anxiety and Depression Scale (HADS) while awaiting their consultation. However, might the context of the clinic
artiﬁcially inﬂate the distress score? To address this question we aimed to determine whether those who scored high
on the HADS in the clinic remained high scorers when reassessed later at home.
Method. We analysed data collected by a distress and depression screening service for cancer out-patients. All
patients had completed the HADS in the clinic (on computer or on paper) prior to their consultation. For a period,
patients with a high score (total of o15) also completed the HADS again at home (over the telephone) 1 week later.
We used these data to determine what proportion remained high scorers and the mean change in their scores. We
estimated the eﬀect of ‘ regression to the mean ’ on the observed change.
Results. Of the 218 high scorers in the clinic, most [158 (72.5%), 95% conﬁdence interval (CI) 66.6–78.4] scored high
at reassessment. The mean fall in the HADS total score was 1.74 (95% CI 1.09–2.39), much of which could be
attributed to the estimated change over time (regression to the mean) rather than the context.
Conclusions. Pre-consultation distress screening in clinic is widely used. Reassuringly, it only modestly over-
estimates distress measured later at home and consequently would result in a small proportion of unnecessary
further assessments. We conclude it is a reasonable and convenient strategy.
Received 21 April 2012 ; Revised 20 September 2012 ; Accepted 23 November 2012 ; First published online 23 January 2013
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Introduction
There is increasing awareness of the importance
of subjective measures including quality of life in
medical care. Such measure are often referred to
as patient-reported outcomes or ‘PROs’ (Greenhalgh,
2009). Emotional distress and depression are im-
portant PROs that have a major eﬀect on quality of
life (Moussavi et al. 2007). Consequently, it has been
recommended that medical patients, such as those
with cancer (Carlson et al. 2012), are screened for
emotional distress and depression (Pignone et al. 2002;
NICE, 2009), but only if there are facilities to provide
treatment for identiﬁed cases (USPSTF, 2009). Despite
an extensive literature on such screening (Carlson et al.
2012), there is limited information on the practicalities
of carrying it out, an important aspect of which is when
and where to administer the screening measures.
The most convenient and widely used strategy is to
administer a questionnaire, such as the Hospital
Anxiety and Depression Scale (HADS; Zigmond &
Snaith, 1983), in the medical clinic, taking advantage
of the time patients spend waiting to go into their
consultation. The patient’s questionnaire score is then
used to determine whether they have a signiﬁcant
level of distress that requires attention and whether
they need a further assessment to determine whether
they have a depressive disorder.
However, there is a potential problem with this
strategy ; measuring distress in the clinic prior to the
consultation might result in a transient inﬂation
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of the score because of the clinical context and the an-
ticipation of the consultation. This phenomenon
would be similar to that referred to as the ‘white-coat
eﬀect ’ in the measurement of blood pressure (Gerin
et al. 2006). If such inﬂation were to occur it would
result in false positives in the identiﬁcation of patients
suﬀering from signiﬁcant distress and would lead to
more patients than necessary being given assessment
interviews for depression. Such an eﬀect would
therefore be important in increasing both incon-
venience to patients and the costs to clinical services.
As far as we are aware, although there are studies of
the test–retest reliability of measures of quality of life
and distress (Hjermstad et al. 1995; Bakker et al. 2009),
the course of distress over a series of cancer consulta-
tions (van Dooren et al. 2005) and of the inﬂuence
of the content of the consultation on distress (van
Dulmen et al. 1995), this particular question has not
been speciﬁcally addressed in the published literature.
We therefore aimed to ﬁnd out whether oncology
patients who were high scorers on the HADS ques-
tionnaire, completed while waiting for their cancer
consultation in clinic, remained high scorers when
completing a repeat HADS questionnaire a week later
at home. Speciﬁcally, we aimed to determine : (a) what
proportion of the patients who scored high (total score
of o15) on the HADS prior to their consultation still
had a high score when reassessed at home 1 week
later ; and (b) how much the mean HADS score had
changed between these two occasions and how much
any fall could be accounted for by regression to the
mean.
Method
To address the research question we analysed data
that had been routinely collected by an established
distress and depression screening service operating in
multiple cancer out-patient clinics in Scotland, UK.
Routine screening procedure
The screening service was in operation in numerous
clinics, each specializing in one of a variety of cancer
types including breast, colorectal, gynaecological, lung
and genito-urinary. All patients attending the clinics
were asked to complete the HADS on touch-screen
computers (or, where computers were not available,
on paper) prior to their medical consultation. The
results of screening were given to their cancer clinician
at the time of the consultation. In addition, all patients
who had scored high on the HADS in clinic were
telephoned at home, approximately 1 week later, and
assessed for depression using the major depression
component of the Structured Clinical Interview for
DSM-IV (SCID; First et al. 1999).
Collection of repeat HADS scores
As part of routine clinical service data collection dur-
ing March and April 2009, patients who had scored
o15 on the HADS in the clinic were asked to complete
the HADS again at home over the telephone, im-
mediately before they were given the routine inter-
view to assess them for depression. We analysed these
clinical data to address the research question.
Ethical approval
We obtained ethical approval from the local Research
Ethics Committee to use the data in this way and also
obtained each patient’s permission to use their an-
onymized clinical data for research.
Measure
The HADS is the most extensively studied distress
scale in cancer patients and is very widely used as a
ﬁrst stage in screening medical patients for depression
(Vodermaier et al. 2009). The HADS asks patients how
they have been feeling over the past 2 weeks. It has
14 items : seven on each of the anxiety and depression
subscales. Each item is rated from 0 to 3, resulting in a
total HADS score between 0 and 42, with higher scores
indicating more severe symptoms (Zigmond & Snaith,
1983) A recent review concluded that the HADS was
an eﬀective measure of emotional distress but that
the subscales were unable to diﬀerentiate consistently
between anxiety and depression (Cosco et al. 2012).
A total HADS score of o15 has been reported to be
optimal to identify cancer patients likely to have major
depression on further assessment (Walker et al. 2007).
Analysis
We analysed these data to determine whether patients
with high HADS scores measured in the clinic prior to
their consultation still had high scores when measured
later at home. We therefore calculated the proportion
of patients who still had a high score (o15) when the
HADS was repeated at home. We also determined the
mean change in the total HADS score between clinic
and home.
Individual patient distress scores vary over time.
Patients scoring high or low are likely to score closer
to the mean score of all assessed patients on later re-
assessment, a phenomenon known as ‘regression to
the mean’. If all patients who completed a ﬁrst HADS
also completed a second HADS, we would expect the
eﬀect of these variations on the mean score of the
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whole group to even out. However, as we only had
follow-up data the subsample of initial high scorers
we would expect the average of the reassessed scores
in this subsample to be lower because of this ‘ re-
gression to the mean’ eﬀect (Barnett et al. 2005).
Therefore, to isolate the eﬀect of the clinic from this
phenomenon we estimated the size of the anticipated
regression to the mean. This involved using more than
5000 HADS scores that had been collected by the
screening service in similar clinics from 2007 to 2010 to
obtain details of the overall distribution of HADS
scores in this population. These details included the
variance and covariance of repeated scores. The tech-
nical details of this approach are provided in the
Appendix and described elsewhere (Das & Mulder,
1983). Finally, we conducted an exploratory analysis
describing and comparing the changes in the HADS
anxiety and depression subscales to determine
whether these diﬀered in the amount they changed.
Results
The service had oﬀered screening to all patients at-
tending the cancer clinics except for a small number
(<5%) who were unable to complete questionnaires
because they were too unwell or had severe cognitive
or communication problems. A further 10% of
patients were missed by the service, mainly because
they were taken straight to their consultation before
being screened, and an additional 7% refused to par-
ticipate in screening.
A total of 1691 patients were screened in clinic
during the period from which the data analysed were
derived. Of these, 395 scored high on the HADS in
clinic and 329 were listed for further assessment at
home (the remainder were not listed for a variety of
reasons including a recent depression assessment,
cognitive or communication problems or exclusion by
their clinician, usually because they were considered
to be too ill). Repeat HADS were not available on 111
of these patients for several reasons, but mainly
because they were not contacted by the screening
service within the 1-month time window used for the
analysis. The ﬁnal patient sample is shown in Fig. 1.
A total of 218 patients were given a repeat HADS
at home by the screening service during the data
collection period. This is the sample analysed.
In the analysed sample, 159 (73%) patients were
female and the median age was 61 years [interquartile
range (IQR) 53–70 years]. Almost all of the patients
were attending follow-up appointments. The median
interval between the clinic and repeat HADS assess-
ments was 6 days (IQR 5–8 days). The 111 patients
who did not have a repeat HADS at home had similar
C ognitive impairment (n = 4)
Exclusion by clinician (n = 8)
Hearing or language difficulties (n = 13)
R ecent interview for depression (n = 41)
Patients reassessed for 
distress and included for 
analysis
(n = 218)
Patients identified with 
distress (HADS ≥ 15) during 
data collection period
(n = 395)
In-patient (n = 1)
Deceased (n = 1)
Refused interview (n = 21)
Could not be contacted within (n = 87)
data collection period
Unknown (n = 1)
Patients eligible for analysis
(n = 329)
Fig. 1. Derivation of patient sample. The patients initially identiﬁed with distress (HADSo15) were screened during
the period from 25 February 2009 to 31 March 2009.
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distributions of sex, age and clinic HADS scores and
attended similar types of cancer clinics. However,
there were more new and good prognosis patients
included in the sample reassessed. The patients’
characteristics and the comparison of those with
and without a HADS rated at home are shown in
Table 1.
Figure 2 shows the distributions of HADS scores
when patients were (a) assessed in clinic and (b) re-
assessed at home. Fig. 3 shows the change in HADS
scores for each individual patient. As a result of the
large variance in the HADS scores, there was also
considerable variability in the change scores between
the two assessments despite a high intra-class corre-
lation between repeated measurements (ICC=0.83).
Almost three-quarters (72.5%; 158/218) of the in-
itial high-scoring patients were still high scorers at
reassessment [95% conﬁdence interval (CI) 66.6–78.4].
The mean change in total HADS score was a reduction
of 1.74 points (95% CI 1.09–2.39).
Table 1. Characteristics of the analysed sample compared with those in the group of eligible patients not included
Eligible patients
included for analysis
(n=218)
Eligible patients not
included for analysis
(n=111) p valuea
Age (years) 0.954
Mean (S.D.) 61.4 (11.5) 61.3 (12.2)
Median (range) 61.4 (25.3–87.7) 62.5 (28.7 to 89.8)
Age categories, n (%) 0.736
f50 years 38 (17) 23 (21)
51–60 years 67 (31) 28 (25)
61–70 years 66 (30) 35 (32)
o71 years 47 (22) 25 (23)
Gender, n (%) 0.396
Male 59 (27) 35 (32)
Female 159 (73) 76 (68)
Cancer clinic type, n (%) 0.383
Breast 83 (38) 39 (35)
Gynaecology 33 (15) 15 (14)
Lung 47 (22) 24 (22)
Colorectal 18 (8) 8 (7)
Urology 14 (6) 12 (11)
Gastrointestinal 15 (7) 4 (4)
Other 8 (4) 9 (8)
Appointment typeb, n (%) 0.025
First appointment 30 (14) 6 (6)
Return appointment 183 (86) 100 (94)
Poor prognosisc, n (%) <0.001
Yes 19 (9) 25 (23)
No 195 (91) 84 (77)
HADS scores 0.356
Mean (S.D.) 20.1 (4.7) 20.6 (4.8)
Median (range) 19 (15–37) 19 (15–34)
HADS score categories, n (%) 0.604
15–19 115 (53) 59 (53)
20–24 66 (30) 29 (26)
o 25 37 (17) 23 (21)
HADS, Hospital Anxiety and Depression Scale ; S.D., standard deviation.
a Age in years and HADS scores were compared using the Wilcoxon rank sum test. All other p values were from x2 tests.
b Appointment type was unknown for 10 patients.
c Poor prognosis was deﬁned for lung (non-lung) cancer patients as a life expectancy of<3 (12) months. Prognosis was
unknown for six patients.
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Our estimate of the regression-to-mean eﬀect was
an average reduction of 1.21 points (95% CI 1.02–1.43).
Hence regression to the mean potentially accounts
for the majority of this observed fall in mean score,
meaning that the eﬀect of measuring in clinic was very
small. The exploratory analysis of changes in HADS
subscales found a mean reduction in the anxiety
subscale of 1.26 points (95% CI 0.84–1.67) and in the
depression subscale of 0.48 points (95% CI 0.12–0.85).
The diﬀerence between the scales in the reduction in
scores was statistically signiﬁcant (p<0.001).
Discussion
We had hypothesized that patients’ HADS scores
might be transiently inﬂated when measured in the
clinic prior to the consultation because of the poten-
tially stressful clinical surroundings and anticipation
of the upcoming appointment. If that were the case it
would question the utility of this widely used strategy
for screening for distress and depression in medical
clinics. We found that the majority of the patients who
scored high on the HADS in clinic prior to their cancer
consultation (72.5%) were still high scorers when re-
assessed at home a week later. That also means that
27.5% of patients who had scored high in the clinic
were no longer high scorers when reassessed later at
home. However, further analysis indicates that despite
large variability at the individual patient level, the
mean HADS total score in the sample fell by only 1.74
points between the two assessments, most of which
could reasonably be attributed to the natural tendency
for individuals who score high on an initial measure-
ment to score lower on later reassessment (regression
to the mean), independent of the setting in which the
measurement was made. Our hypothesis was there-
fore not supported and measuring distress in the clinic
prior to the consultation is a reasonable strategy to
adopt.
There was considerable individual variability in the
size of change scores between the two assessments
(a)
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Fig. 2. Hospital Anxiety and Depression Scale (HADS) scores of patients (n=218) in the study sample (a) when assessed
in clinic and (b) when reassessed at home.
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Fig. 3. Change in Hospital Anxiety and Depression Scale
(HADS) total score from clinic to follow-up at home plotted
against initial HADS score in clinic. Circles indicate patients
whose reassessment score fell below 15. Patients plotted
above the dashed line had a higher HADS score on
reassessment whereas those below the line had a lower score.
A degree of ‘ jitter ’ was applied to separate out overlapping
data points.
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despite a high intra-class correlation between repeated
measurements from the same patient. This was due
to large overall variance in the scores, a property
common to measures of psychological distress. It is
unclear whether this variation is due to a large
random error in the measurements or a reﬂection
of actual ﬂuctuations in the severity of distress over
time. Nonetheless, our sample of 218 patients was
suﬃciently large to estimate the mean change for the
sample with reasonable accuracy.
It is notable that, whereas the screening service used
the total score in the HADS to deﬁne signiﬁcant dis-
tress, the fall in score was slightly larger on the anxiety
subscale. This may be because the consultation has a
greater transient eﬀect on anxiety than on depression.
It may also imply that scales that measure only de-
pressive symptoms are even less subject to a clinic
eﬀect.
We are not aware of any studies that have directly
addressed the question we have posed. We identiﬁed
a test–retest reliability study of the European
Organization for Research and Treatment of Cancer
(EORTC) quality of life measures, which include
emotional functioning, that compared questionnaire
scores administered to 270 patients attending routine
post-treatment follow-up visits to cancer clinics with
their score at home 4 days later and found generally
good agreement (Hjermstad et al. 1995). Other studies
that have administered repeated psychological as-
sessment have examined distress trajectories over
longer periods of time (Hinnen et al. 2008) or before
and after consultations (van Dooren et al. 2005) but we
found none that directly addressed the possible eﬀect
of the clinical context on the measurement score.
There were limitations to this study. First, we ana-
lysed data collected by a routine screening service
operating in cancer clinics ; the ﬁndings may not
therefore generalize to other clinical settings. Second,
the service administered a second HADS only to
patients who had scored high in clinic. This meant
that our observed HADS scores obtained at home
underestimated the true proportion of patients who
would have scored high had all patients been re-
assessed, as it would be likely that some of the patients
who scored low in clinic would have scored high on
the second occasion. This limitation was addressed
by estimating the regression to the mean. Third, there
were missing data from patients who could not be
contacted during the limited time window in which
repeat HADS were administered. However, the
characteristics of patients on whom we had analy-
sable data and those on whomwe did not were mostly
similar ; systematic bias is therefore unlikely. Fourth,
there may be limits to the intrinsic test–retest re-
liability of the HADS (as opposed to real changes in
symptoms) but this is unlikely to be large over this
time period, or to represent a systematic bias. Fifth,
patients completed the HADS on a touch-screen com-
puter or on paper in the clinic, but the follow-up
assessment was carried out by reading out the scale
over the telephone. It is possible that administering
the HADS over the telephone causes patients to score
diﬀerently. Previous studies have found good agree-
ment between self-completed and verbally completed
distress screening questionnaires, with a tendency for
the latter to record a lower score (Pinto-Meza et al.
2005; Cheung et al. 2006). Such a bias, if present, would
reduce further the observed fall in HADS score at-
tributable to the eﬀect of measurement in the clinic.
Future studies could use the same mode of adminis-
tration to avoid this issue. Sixth, the content of the
consultation and its meaning for the patient, whether
positive or negative, might have accounted for some
of the changes in scores and we were not able to assess
this. However, most of the consultations were for
follow-up and not for the communication of new
diagnoses. The eﬀect of consultation type could be
addressed in future studies. Seventh, because the
results of the screening were given to the clinician be-
fore the consultation, it is possible that they might
have taken action to address the distress, for example
by referring the patient for psychological treatment.
This is, however, very unlikely to have occurred
within 1 week. Finally, although the average change
in scores was small, the intra-patient variability was
high, with some patients scoring very diﬀerently on
reassessment. It is possible, therefore, that a minority
of patients are aﬀected considerably by the clinic set-
ting. Consequently, we cannot rule out the possibility
of an important ‘clinic eﬀect ’ for some individuals.
Conclusions
In conclusion, most patients who scored high on the
HADS administered in clinic prior to their medical
consultation remained high scorers when reassessed
at home a week later. There was only a small reduction
in mean score, most of which could be attributed to
regression to the mean. Therefore, the widely used
strategy of asking patients to complete a screening
questionnaire for distress while they wait for their
clinic appointment is a reasonable method of identi-
fying those who have signiﬁcant distress and also a
useful ﬁrst step in identifying those who require an
interview for the assessment of possible depressive
disorder. The increasing use of telephones and the in-
ternet provides opportunities to screen patients away
from the clinic, thereby potentially avoiding the
issue of clinic context. However, the pre-consultation
waiting time has long provided an opportunity to
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undertake such clinic-based screening, and is likely
to continue to do so in the future.
Appendix
Estimating the regression-to-the-mean eﬀect
As only patients with an initial high score were
followed up, the scores on reassessment were subject
to regression to the mean. We estimated the average
drop in scores caused by this eﬀect as follows.
Suppose that a patient’s HADS score, H, is the sum
of their (constant) true underlying score, S, and an
independent error term, e, where S is distributed
according to some arbitrary density function with
variance ss
2 and the errors are normally distributed
with mean 0 and variance se
2. The total variance is
then Var(H)=st2=ss2+se2 and r=ss2/st2 is the intra-
patient correlation between repeated scores from the
same individual.
We wanted to estimate the expected diﬀerence
between a pair of repeated HADS scores, H1 and H2,
conditional on H1 being o15. That is, we wanted to
estimate E[H1 – H2jH1 o15].
For a continuous H it can be shown that
E [H1xH2 H1>hcj ]=(1xr)s2t
g(hc)
1xG(hc)
;
where g(hc) is the probability density function for
H evaluated at hc, and G(hc) is the corresponding
cumulative distribution function (Das & Mulder,
1983). From the large sample of scores collected by the
screening service in similar clinics from 2007 to 2010,
we obtained empirical estimates of g(hc) and G(hc).
Using data from the 5215 patients who had HADS
scores measured in subsequent clinic visits during
this period, we estimated st
2 and r as the correlation of
scores obtained 1 week apart. We did this by model-
ling the covariance matrix of repeated scores in a lin-
ear regression with random intercept and exponential
covariance structure to account for a decreasing cor-
relation over time. A 95% quantile-based CI for the
regression-to-mean estimate was derived through
bootstrapping.
Although technically a discrete scale, we applied
the HADS (range 0–42) with the above result, in-
troducing a continuity correction by evaluating g(.)
and G(.) at hc=14.5 by approximating a theoretical
continuous curve. The approach was veriﬁed through
simulation studies and sensitivity analysis.
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